Data / Form D filings / Strategikon Pharma, Inc.
Strategikon Pharma, Inc.: Form D filings
Strategikon Pharma, Inc., a technology company in San Francisco, CA, filed 3 Form D notices with the SEC between 2017 and 2025. The latest, on November 21, 2025, reports $2.3 million sold of a $3 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 Sansome Street, 35th Floor PMB #40621, San Francisco, CA, 94104
- Phone
- (609) 529-7806
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1722200
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | New notice | $3,000,000 | $2,291,885 | $708,115 | 15 | May 8, 2025 | sec.gov |
| Apr 6, 2018 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Nov 15, 2017 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rob Hess | Director | |
| Anca Copaescu | Executive Officer, Director | |
| Debra Apruzzese | Director | |
| Chris Codeanne | Director | |
| Paulo Carvalho | Executive Officer | |
| Vincent Lepreux | Director | |
| Mark Weinstein | Executive Officer, Director | |
| Nathanael Lentz | Director |
Other technology companies in California that filed recently
- OutLens, Inc. $32,000 · Nov 2, 2026
- ECFX, Inc. offering · Nov 2, 2026
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Strategikon Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.